Ultralife ULBI
Ultralife reports strong Q3 2026 results
Ultralife (ULBI) filed an 8-K with the SEC on Nov 9, 2026, 3:38 pm ET. Source: the filing on SEC EDGAR.
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001437749-26-035865
- Sales of $48.3 million, up 11.3% from $43.4 million in Q3 2025
- Gross profit of $13.3 million, or 27.5% of revenue, compared to $9.6 million in Q3 2025
- GAAP EPS of $0.14, up from ($0.07) in Q3 2025
- Backlog of $136.0 million, the highest in company history
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
